Le Lézard
Classified in: Environment, Health
Subjects: SVY, DEI, ESG

Artivion Publishes Inaugural Corporate Responsibility Report


ATLANTA, March 14, 2022 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today published its inaugural Corporate Responsibility Report detailing the company's Environmental, Social, and Governance (ESG) initiatives.

Artivion's 2022 Corporate Responsibility Report details several of the company's ESG efforts, including:

"Our mission is to partner with surgeons to restore the health of patients by delivering innovative technologies of unsurpassed quality. At Artivion, we believe we can best fulfill this mission by taking a responsible approach to mitigate our impact on the environment while acting as a responsible global and local citizen across the communities in which we operate and by maintaining a culture of integrity, respect, and inclusiveness for all of our employees," said Pat Mackin, Chairman, President, and Chief Executive Officer of Artivion. "We are proud to share our accomplishments across each of these critical focus areas in our first ever Corporate Responsibility Report, and we look forward to continuing to enhance our ESG efforts in meaningful and impactful ways."

Artivion's 2022 Corporate Responsibility Report aims to address the company's diverse stakeholders. Please visit the Corporate Governance section of the company's website at www.artivion.com to view Artivion's 2022 Corporate Responsibility Report.

About Artivion, Inc.
Headquartered in suburban Atlanta, Georgia, Artivion, Inc. is a medical device company focused on developing simple, elegant solutions that address cardiac and vascular surgeons' most difficult challenges in treating patients with aortic diseases. Artivion's four major groups of products include: aortic stents and stent grafts, surgical sealants, On-X mechanical heart valves, and implantable cardiac and vascular human tissues. Artivion markets and sells products in more than 100 countries worldwide. For additional information about Artivion, visit our website, www.artivion.com.

Forward Looking Statements
Statements made in the Corporate Responsibility Report that look forward in time or that express management's beliefs, expectations, or hopes are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements reflect the views of management at the time such statements are made. These statements include our belief that we can best fulfill our mission by taking a responsible approach to our impact on the environment, being a good citizen of the communities in which we operate, and maintaining a culture of integrity, respect, and inclusiveness for all of our employees and that we look forward to continuing to enhance our ESG efforts in meaningful and impactful ways. These forward-looking statements are subject to a number of risks, uncertainties, estimates, and assumptions that may cause actual results to differ materially from current expectations. These risks and uncertainties include the risk factors detailed in our Securities and Exchange Commission filings, including our Form 10-K for year ended December 31, 2021. Artivion does not undertake to update its forward-looking statements, whether as a result of new information, future events, or otherwise.

Contacts:


Artivion

Gilmartin Group LLC

D. Ashley Lee

Brian Johnston / Lynn Lewis

Executive Vice President
& Chief Financial Officer

Phone:  332-895-3222

Chief Financial Officer

[email protected]

Phone: 770-419-3355


 

SOURCE Artivion, Inc.


These press releases may also interest you

at 18:00
Bridge Biotherapeutics (KQ288330), a South Korean clinical-stage biotech company developing novel drugs for cancer, fibrosis, and inflammation, announced a research collaboration with Dr. Jessica M. Konen's Lab at Emory University School of Medicine....

at 17:58
More than 200 workers at American Medical Response (AMR) in Springfield and Greenfield have voted overwhelmingly to join Teamsters Local 404....

at 17:54
The American Association of Kidney Patients (AAKP), the largest and oldest independent kidney patient organization in the nation, is celebrating National Doctors Day by highlighting three top kidney medical experts and authors known for their...

at 17:20
Adicet Bio, Inc. , a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today announced it granted an inducement award on March 28, 2024. One individual was...

at 17:15
Paladin Labs Inc., a subsidiary of Endo International plc , today announced Health Canada's approval of WAKIX® (pitolisant hydrochloride tablets) for the treatment of excessive daytime sleepiness (EDS) or cataplexy in pediatric patients aged 6 years...

at 17:05
Sirona Biochem Corp. ("Sirona") announces the voting results from its Annual General Meeting of Shareholders (the "Meeting"), held in Vancouver, British Columbia on March 28, 2024. The total number of shares represented by shareholders present in...



News published on and distributed by: